Aditya Birla Sun Life Mutual Fund
When comparing, both lines start at 100. Tradinity's reference for the category: a total-return index (dividends reinvested). The fund's declared benchmark (BSE Healthcare TRI) is not available to us as a series.
This is an IDCW (dividend) option: it pays cash out of its NAV, so returns computed from the NAV alone would understate what an investor earned. See the Growth option of the same plan for performance.
Computed from this fund's actual NAVs. A SIP buys at the first NAV of each month and is valued at the latest NAV. Past returns do not guarantee future ones.
Weights are % of the scheme's assets from the latest month-end disclosure available to Tradinity. The feed carries weights only: no quantities or rupee values.
Valuation ratios are weighted over the holdings we can match to a company (harmonic mean for P/E) and are withheld when they cover under half the portfolio.
| Equity | 97.61% |
| Cash & Equivalents | 2.39% |
Click a sector to filter the holdings below (holdings map to our sector list where the company is known).
| Holding | Sector | Weight | 3M change | P/E |
|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd | Healthcare | 9.94% | 5.18 pp | 78.2 |
| Sun Pharmaceutical Industries Ltd | Healthcare | 9.75% | -3.42 pp | 146.5 |
| Apollo Hospitals Enterprise Limited | Healthcare | 7.08% | -0.12 pp | 74.7 |
| Cipla Ltd | Healthcare | 4.56% | 1.25 pp | 35.4 |
| Aurobindo Pharma Ltd | Healthcare | 4.29% | -0.21 pp | 37.4 |
| Ajanta Pharma Limited | Healthcare | 4.17% | 0.12 pp | 44.9 |
| Sai Life Sciences Limited | Healthcare | 3.89% | 1.69 pp | 90.6 |
| Mankind Pharma Ltd | Healthcare | 3.58% | -0.30 pp | 47.4 |
| Lupin Limited | Healthcare | 3.51% | -0.48 pp | 13.3 |
| Abbott India Ltd | Healthcare | 3.35% | -0.30 pp | 35.7 |
| Emcure Pharmaceuticals Ltd | Healthcare | 3.24% | -0.07 pp | 45.5 |
| Fortis Healthcare Ltd | Healthcare | 2.98% | -0.88 pp | 257.5 |
| IPCA Laboratories Ltd | Healthcare | 2.47% | -0.40 pp | 39.3 |
| Gland Pharma Ltd | Healthcare | 2.34% | 1.37 pp | 34.3 |
| Shilpa Medicare Ltd | Healthcare | 2.32% | -0.20 pp | 111.8 |
| TREPS | — | 2.30% | 2.30 pp | — |
| Corona Remedies Ltd | Healthcare | 2.29% | 0.04 pp | 64.5 |
| Procter & Gamble Health Ltd | Healthcare | 2.16% | 0.13 pp | 25.9 |
| Dr. Lal PathLabs Ltd | Healthcare | 2.12% | 1.18 pp | 38.7 |
| Jupiter Life Line Hospitals Ltd | Healthcare | 2.03% | 0.24 pp | 9.0 |
| Divi's Laboratories Ltd | Healthcare | 1.95% | 0.07 pp | 83.9 |
| Thyrocare Technologies Limited | Healthcare | 1.91% | 0.34 pp | 34.1 |
| Alkem Laboratories Ltd | Healthcare | 1.88% | -0.22 pp | 28.9 |
| Metropolis Healthcare Ltd | Healthcare | 1.59% | 0.17 pp | 27.5 |
| Sanofi Consumer Healthcare India Ltd | Healthcare | 1.36% | -0.31 pp | 32.9 |
| Pfizer Ltd | Healthcare | 1.26% | -0.08 pp | 24.1 |
| Biocon Limited | Healthcare | 1.26% | 0.17 pp | 597.3 |
| Piramal Pharma Ltd (Mumbai) | Healthcare | 1.16% | 0.12 pp | 39.2 |
| Anthem Biosciences Limited | Healthcare | 1.07% | -0.13 pp | 77.2 |
| Dr. Reddy's Laboratories Limited | Healthcare | 1.06% | -0.40 pp | 154.7 |
| Vijaya Diagnostic Centre Limited | Healthcare | 0.98% | -0.00 pp | 76.7 |
| Manipal Health Enterprises Limited | Healthcare | 0.89% | 0.89 pp | — |
| Medi Assist Healthcare Services Ltd | Financial Services | 0.87% | -0.13 pp | 38.8 |
| GlaxoSmithKline Pharmaceuticals Ltd | Healthcare | 0.80% | -0.05 pp | 44.3 |
| Suraksha Diagnostic Ltd | Healthcare | 0.79% | -0.27 pp | 50.3 |
| Vinati Organics Limited | Chemicals | 0.78% | 0.08 pp | 24.3 |
| Max Healthcare Institute Limited | Healthcare | 0.72% | -0.06 pp | 126.0 |
| Syngene International Ltd | Healthcare | 0.68% | 0.68 pp | 64.2 |
| Jubilant Pharmova Ltd | Healthcare | 0.55% | -0.65 pp | 709.5 |
| Net Receivable / Payable | — | 0.09% | 0.09 pp | — |
Expense ratio by month: Oct 25 1.03% · Nov 25 1.02% · Dec 25 1.02% · Jan 26 1.02% · Feb 26 1.02% · Mar 26 1.02% · Apr 26 1.01% · May 26 0.99% · Jun 26 1.01% · Jul 26 1.01% · Aug 26 1.02% · Sep 26 1.05%
For redemption/switch-out of units on or before 30 days from the date of allotment: 1.00% of applicable NAV. For redemption/switch-out of units after 30 days from the date of allotment: Nil
Fund house: website · factsheets · monthly portfolio · annual report
Not available: Morningstar rating (proprietary). "NAV history from" is the first NAV we hold.
Returns are computed by Tradinity from each scheme's own published NAV, so they are net of the fund's expenses. Periods over one year are annualised (CAGR). Past performance does not indicate future returns. Only Growth-option schemes are ranked: an IDCW scheme pays cash out of its NAV, so its NAV understates what an investor earned.
